Circ J 2009; 73: 288 -294 ardiac resynchronization therapy (CRT) improves the quality of life, symptoms, and exercise capacity of patients with drug-refractory congestive heart failure (HF) and intraventricular conduction delays. 1 In addition, CRT has resulted in a reduction in HF hospitalizations and the risk of death. 1,2 However, the indication for CRT remains limited by a fairly high percentage of nonresponsive patients. 1,3 Previous reports have suggested that baseline mechanical ventricular dyssynchrony may predict the hemodynamic response to CRT, 4,5 but there are some non-responders to CRT despite an improvement in the left ventricular (LV) dyssynchrony. Thus, predictors of CRT response and the long-term outcome of CRT have not been sufficiently clarified.Atrial fibrillation (AF) often occurs in patients with advanced HF and in CRT recipients, 6,7 but previous large trials have examined the effectiveness of CRT only in patients with sinus rhythm (SR). 1-4 Therefore, the efficacy and safety of CRT for patients with AF have not been fully established.The purpose of this study was to identify CRT responders in order to predict the short-and long-term clinical outcomes and to examine the efficacy of CRT in patients with AF.
Methods
Study PopulationThis study included 43 patients (10 women; mean age, 66±9 years) with advanced HF and a wide QRS complex who received a pacemaker or implantable cardioverter defibrillator providing biventricular pacing (Table 1). Fourteen (33%) patients had ischemic heart disease, 24 (56%) had idiopathic cardiomyopathy, 2 (5%) had valvular heart disease, 1 (2%) had arrhythmogenic right ventricular (RV) cardiomyopathy, and the remaining 2 (5%) had cardiac sarcoidosis. At the time of CRT, 18 (42%) patients were in New York Heart Association (NYHA) function class 4, and the remaining 25 (58%) were in class 3 despite maximal pharmacologic therapy before CRT. In all patients, the total QRS duration was >140 ms (range, 140-280 ms) and the LV ejection fraction (LVEF) determined by echocardiography was <40% (mean LVEF, 25±11%) with extensive dilation of the left ventricle (LV end-diastolic dimension, 70±11 mm; Table 1). In total, 20 (47%) patients had chronic AF and the remaining 23 (53%) were in SR.After assessing the patients' clinical status and examining their cardiac function by echocardiography before and 1 month after CRT initiation, they were divided into 2 groups: responders and non-responders. A responder was defined as a patient who improved clinically to NYHA function class I or II during the follow-up period and whose LV endsystolic volume (LVESV) decreased by 10% and/or LVEF (Received June 6, 2008; revised manuscript received September 20, 2008; accepted October 7, 2008; released online December 26, 2008 Background The aim of this study was to retrospectively investigate the long-term effect of cardiac resynchronization therapy (CRT) and to clarify the useful predictors of clinical outcome.
Methods and ResultsThe study group comprised 43 patients with advanced heart fa...